Literature DB >> 25211074

The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon.

Maudry Laurent-Rolle1,2, Juliet Morrison1,2, Ricardo Rajsbaum1,2, Jesica M Levingston Macleod1,2, Giuseppe Pisanelli1,2,3, Alissa Pham1,2, Juan Ayllon1,2, Lisa Miorin1,2, Carles Martinez1,2, Benjamin R tenOever1,2, Adolfo García-Sastre1,2,4.   

Abstract

To successfully establish infection, flaviviruses have to overcome the antiviral state induced by type I interferon (IFN-I). The nonstructural NS5 proteins of several flaviviruses antagonize IFN-I signaling. Here we show that yellow fever virus (YFV) inhibits IFN-I signaling through a unique mechanism that involves binding of YFV NS5 to the IFN-activated transcription factor STAT2 only in cells that have been stimulated with IFN-I. This NS5-STAT2 interaction requires IFN-I-induced tyrosine phosphorylation of STAT1 and the K63-linked polyubiquitination at a lysine in the N-terminal region of YFV NS5. We identified TRIM23 as the E3 ligase that interacts with and polyubiquitinates YFV NS5 to promote its binding to STAT2 and trigger IFN-I signaling inhibition. Our results demonstrate the importance of YFV NS5 in overcoming the antiviral action of IFN-I and offer a unique example of a viral protein that is activated by the same host pathway that it inhibits.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25211074      PMCID: PMC4176702          DOI: 10.1016/j.chom.2014.07.015

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  54 in total

Review 1.  Viral hijacking of cellular ubiquitination pathways as an anti-innate immunity strategy.

Authors:  Mingzhou Chen; Denis Gerlier
Journal:  Viral Immunol       Date:  2006       Impact factor: 2.257

2.  Yellow fever 17D vaccine safety and immunogenicity in the elderly.

Authors:  Thomas P Monath; Martin S Cetron; Karen McCarthy; Richard Nichols; W Tad Archambault; Leisa Weld; Philip Bedford
Journal:  Hum Vaccin       Date:  2005-09-02

3.  17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005.

Authors:  Alan D T Barrett; Thomas P Monath; Veronique Barban; Matthias Niedrig; Dirk E Teuwen
Journal:  Vaccine       Date:  2006-12-28       Impact factor: 3.641

4.  Structure and function of flavivirus NS5 methyltransferase.

Authors:  Yangsheng Zhou; Debashish Ray; Yiwei Zhao; Hongping Dong; Suping Ren; Zhong Li; Yi Guo; Kristen A Bernard; Pei-Yong Shi; Hongmin Li
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

5.  CHIP deletion reveals functional redundancy of E3 ligases in promoting degradation of both signaling proteins and expanded glutamine proteins.

Authors:  Yoshihiro Morishima; Adrienne M Wang; Zhigang Yu; William B Pratt; Yoichi Osawa; Andrew P Lieberman
Journal:  Hum Mol Genet       Date:  2008-09-10       Impact factor: 6.150

6.  NS5 of dengue virus mediates STAT2 binding and degradation.

Authors:  Joseph Ashour; Maudry Laurent-Rolle; Pei-Yong Shi; Adolfo García-Sastre
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

7.  TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity.

Authors:  Michaela U Gack; Young C Shin; Chul-Hyun Joo; Tomohiko Urano; Chengyu Liang; Lijun Sun; Osamu Takeuchi; Shizuo Akira; Zhijian Chen; Satoshi Inoue; Jae U Jung
Journal:  Nature       Date:  2007-04-19       Impact factor: 49.962

8.  Tick-borne encephalitis virus NS5 associates with membrane protein scribble and impairs interferon-stimulated JAK-STAT signalling.

Authors:  Karin Werme; Michael Wigerius; Magnus Johansson
Journal:  Cell Microbiol       Date:  2007-11-27       Impact factor: 3.715

9.  Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases.

Authors:  Zhangle Zhou; Ole J Hamming; Nina Ank; Søren R Paludan; Anders L Nielsen; Rune Hartmann
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

10.  Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses.

Authors:  Natalia Frias-Staheli; Nadia V Giannakopoulos; Marjolein Kikkert; Shannon L Taylor; Anne Bridgen; Jason Paragas; Juergen A Richt; Raymond R Rowland; Connie S Schmaljohn; Deborah J Lenschow; Eric J Snijder; Adolfo García-Sastre; Herbert Whiting Virgin
Journal:  Cell Host Microbe       Date:  2007-12-13       Impact factor: 21.023

View more
  82 in total

1.  Binding of Duck Tembusu Virus Nonstructural Protein 2A to Duck STING Disrupts Induction of Its Signal Transduction Cascade To Inhibit Beta Interferon Induction.

Authors:  Wei Zhang; Bowen Jiang; Miao Zeng; Yanping Duan; Zhen Wu; Yuanyuan Wu; Tao Wang; Mingshu Wang; Renyong Jia; Dekang Zhu; Mafeng Liu; Xinxin Zhao; Qiao Yang; Ying Wu; Shaqiu Zhang; Yunya Liu; Ling Zhang; Yanling Yu; Leichang Pan; Shun Chen; Anchun Cheng
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

2.  Nonstructural Protein 11 of Porcine Reproductive and Respiratory Syndrome Virus Induces STAT2 Degradation To Inhibit Interferon Signaling.

Authors:  Liping Yang; Jia He; Rong Wang; Xinheng Zhang; Shaoli Lin; Zexu Ma; Yanjin Zhang
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

Review 3.  Structure and function of Zika virus NS5 protein: perspectives for drug design.

Authors:  Boxiao Wang; Stephanie Thurmond; Rong Hai; Jikui Song
Journal:  Cell Mol Life Sci       Date:  2018-02-08       Impact factor: 9.261

Review 4.  TRIM Proteins and Their Roles in Antiviral Host Defenses.

Authors:  Michiel van Gent; Konstantin M J Sparrer; Michaela U Gack
Journal:  Annu Rev Virol       Date:  2018-06-27       Impact factor: 10.431

5.  Comparative Flavivirus-Host Protein Interaction Mapping Reveals Mechanisms of Dengue and Zika Virus Pathogenesis.

Authors:  Priya S Shah; Nichole Link; Gwendolyn M Jang; Phillip P Sharp; Tongtong Zhu; Danielle L Swaney; Jeffrey R Johnson; John Von Dollen; Holly R Ramage; Laura Satkamp; Billy Newton; Ruth Hüttenhain; Marine J Petit; Tierney Baum; Amanda Everitt; Orly Laufman; Michel Tassetto; Michael Shales; Erica Stevenson; Gabriel N Iglesias; Leila Shokat; Shashank Tripathi; Vinod Balasubramaniam; Laurence G Webb; Sebastian Aguirre; A Jeremy Willsey; Adolfo Garcia-Sastre; Katherine S Pollard; Sara Cherry; Andrea V Gamarnik; Ivan Marazzi; Jack Taunton; Ana Fernandez-Sesma; Hugo J Bellen; Raul Andino; Nevan J Krogan
Journal:  Cell       Date:  2018-12-13       Impact factor: 41.582

6.  To TRIM or not to TRIM: the balance of host-virus interactions mediated by the ubiquitin system.

Authors:  Adam Hage; Ricardo Rajsbaum
Journal:  J Gen Virol       Date:  2019-12       Impact factor: 3.891

Review 7.  The Many Faces of the Flavivirus NS5 Protein in Antagonism of Type I Interferon Signaling.

Authors:  Sonja M Best
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

8.  Host-Specific NS5 Ubiquitination Determines Yellow Fever Virus Tropism.

Authors:  Lisa Miorin; Maudry Laurent-Rolle; Giuseppe Pisanelli; Pierre Hendrick Co; Randy A Albrecht; Adolfo García-Sastre; Juliet Morrison
Journal:  J Virol       Date:  2019-06-28       Impact factor: 5.103

9.  Flavivirus Antagonism of Type I Interferon Signaling Reveals Prolidase as a Regulator of IFNAR1 Surface Expression.

Authors:  Kirk J Lubick; Shelly J Robertson; Kristin L McNally; Brett A Freedman; Angela L Rasmussen; R Travis Taylor; Avram D Walts; Seitaro Tsuruda; Mizuki Sakai; Mariko Ishizuka; Elena F Boer; Erin C Foster; Abhilash I Chiramel; Conrad B Addison; Richard Green; Daniel L Kastner; Michael G Katze; Steven M Holland; Antonella Forlino; Alexandra F Freeman; Manfred Boehm; Kentaro Yoshii; Sonja M Best
Journal:  Cell Host Microbe       Date:  2015-07-08       Impact factor: 21.023

10.  A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B Protein.

Authors:  Fang Guo; Shuo Wu; Justin Julander; Julia Ma; Xuexiang Zhang; John Kulp; Andrea Cuconati; Timothy M Block; Yanming Du; Ju-Tao Guo; Jinhong Chang
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.